ArticleOncotarget2016

CK2 targeted RNAi therapeutic delivered via malignant cell-directed tenfibgen nanocapsule: dose and molecular mechanisms of response in xenograft prostate tumors.

Khalil Ahmed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.